{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:22:49Z","timestamp":1788564169358,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajog.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:53:46Z","timestamp":1763031226000},"page":"834-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy"],"prefix":"10.1016","volume":"234","author":[{"given":"Anders H.","family":"Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius F.","family":"Calsavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged M.","family":"Costantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair J.","family":"Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany A.","family":"Moore Simas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judette M.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Gaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Murtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Gollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepjot","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol R.","family":"Norwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Plunkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-6831","authenticated-orcid":false,"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.11.006_bib1","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28093","article-title":"Association of birth year of pregnant individuals with trends in hypertensive disorders of pregnancy in the United States, 1995\u20132019","volume":"5","author":"Cameron","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.11.006_bib3","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"ACOG practice bulletin summary, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajog.2025.11.006_bib5","series-title":"Delivery hospitalizations involving preeclampsia and eclampsia, 2005\u20132014","author":"Fingar","year":"2017"},{"key":"10.1016\/j.ajog.2025.11.006_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.preghy.2018.05.008","article-title":"Angiogenic biomarkers in triage and risk for preeclampsia with severe features","volume":"13","author":"Rana","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2025.11.006_bib7","doi-asserted-by":"crossref","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century","volume":"226","author":"Fishel Bartal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2022.2160627","article-title":"Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features","volume":"36","author":"Greiner","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2025.11.006_bib9","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1701-2163(16)35015-0","article-title":"The role of platelet counts in the assessment of inpatient women with preeclampsia","volume":"33","author":"Laskin","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2025.11.006_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2025.11.006_bib12","doi-asserted-by":"crossref","first-page":"28.e1","DOI":"10.1016\/j.ajog.2007.04.010","article-title":"Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy","volume":"197","author":"Salahuddin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10641955.2016.1148162","article-title":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes","volume":"35","author":"Salahuddin","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2025.11.006_bib14","doi-asserted-by":"crossref","first-page":"40.e1","DOI":"10.1016\/j.ajog.2009.07.025","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume":"202","author":"Sunderji","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib15","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young investigator award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/14767058.2013.806905","article-title":"Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study","volume":"27","author":"Chaiworapongsa","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2025.11.006_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2020.11.007","article-title":"Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of \u226585 for ruling in preeclampsia within 4 weeks","volume":"224","author":"Cerdeira","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib18","doi-asserted-by":"crossref","first-page":"S1048","DOI":"10.1016\/j.ajog.2020.09.046","article-title":"The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia","volume":"226","author":"Verlohren","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian Women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.11.006_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2025.11.006_bib21","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ajog.2025.11.006_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/AOG.0000000000005532","article-title":"Angiogenic biomarkers in preeclampsia","volume":"143","author":"Burwick","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib24","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2024.07.015","article-title":"Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1\/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy","volume":"232","author":"Burns","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.11.006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263443","article-title":"sFlt-1\/PlGF ratio for prediction of preeclampsia in clinical routine: a pragmatic real-world analysis of healthcare resource utilisation","volume":"17","author":"Dathan-Stumpf","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.11.006_bib27","doi-asserted-by":"crossref","first-page":"S1037","DOI":"10.1016\/j.ajog.2020.10.028","article-title":"Real-world data on the clinical use of angiogenic factors in pregnancies with placental dysfunction","volume":"226","author":"Dathan-Stumpf","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.11.006_bib28","article-title":"FDA provides draft recommendations to diagnostic manufacturers to help reduce risks of biotin interference with certain lab tests","year":"2019","journal-title":"Food and Drug Administration"},{"key":"10.1016\/j.ajog.2025.11.006_bib30","series-title":"The statistical evaluation of medical tests for classification and prediction","author":"Pepe","year":"2003"},{"key":"10.1016\/j.ajog.2025.11.006_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.ajog.2025.11.006_bib32","series-title":"Flexible imputation of missing data","author":"Van Buuren","year":"2012"},{"key":"10.1016\/j.ajog.2025.11.006_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044480","article-title":"Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics","volume":"11","author":"Pong","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2025.11.006_bib34","series-title":"Development CORE Team. A Language and Environment for Statistical Computing","year":"2025"},{"key":"10.1016\/j.ajog.2025.11.006_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine Kinase-1\/Placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.11.006_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2025.11.006_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.602560","article-title":"Short-term prediction of preeclampsia in Chinese women using the soluble fms-like tyrosine kinase 1\/placental growth factor ratio: a sub-analysis of the PROGNOSIS Asia Study","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajog.2025.11.006_bib38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41440-021-00629-x","article-title":"Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study","volume":"44","author":"Ohkuchi","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2025.11.006_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jalm\/jfaf063","article-title":"Reference range determination for the sFlt-1\/PlGF ratio in a diverse cohort of pregnant women in the United States","volume":"10","author":"Saad","year":"2025","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.ajog.2025.11.006_bib40","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301808R","article-title":"Translation of mechanistic advances in preeclampsia to the clinic: long and winding road","volume":"38","author":"Thadhani","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2025.11.006_bib41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman Primates","volume":"67","author":"Makris","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2025.11.006_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","volume":"36","author":"Turanov","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajog.2025.11.006_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2025.11.006_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble Fms-like tyrosine Kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2025.11.006_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:53:43Z","timestamp":1781006023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825008282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0002937825008282"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.11.006","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}